Ascendis Pharma A/S ASND
$252.73 −$3.23 (-1.26%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $252.73 0.00%
Open$255.44
Prev close$255.96
Day range$251.55 – $256.65
Volume602.9K
Market cap$16.63B
P/E (TTM)34.7
Dividend yield–
Analyst view
ConsensusBuy
Analysts20
Average target$320.00+26.6% vs. price
- Buy 95%
- Hold 5%
Low $274.00Now $252.73Avg $320.00High $356.00
Recent rating changes
The last 20 actions on file set price targets from $273.00 to $356.00, averaging $319.60.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 16 Nov 2026 | Citi | BUY | $335.00 |
| 16 Nov 2026 | Barclays | BUY | $341.00 |
| 13 Nov 2026 | TD Cowen | BUY | $352.00 |
| 13 Nov 2026 | CCORF | HOLD | $274.00 |
| 13 Nov 2026 | Wells Fargo | BUY | $330.00 |
| 13 Nov 2026 | UBS | BUY | $315.00 |
| 13 Nov 2026 | Wedbush | BUY | $346.00 |
| 13 Nov 2026 | Morgan Stanley | BUY | $302.00 |
| 13 Nov 2026 | Evercore | BUY | $356.00 |
| 13 Nov 2026 | Leerink Partners | BUY | $326.00 |
| 13 Nov 2026 | H.C. Wainwright | BUY | $335.00 |
| 13 Nov 2026 | Barclays | BUY | $341.00 |
| 12 Nov 2026 | BofA Securities | BUY | $304.00 |
| 12 Nov 2026 | RBC Capital | BUY | $290.00 |
| 10 Nov 2026 | TD Cowen | BUY | $352.00 |
| 9 Nov 2026 | Morgan Stanley | BUY | $273.00 |
| 9 Nov 2026 | H.C. Wainwright | BUY | $344.00 |
| 2 Nov 2026 | Morgan Stanley | BUY | $273.00 |
| 26 Oct 2026 | Morgan Stanley | BUY | $273.00 |
| 26 Oct 2026 | Citi | BUY | $330.00 |
No comments yet — be the first to weigh in on ASND.
Sign in to join the discussion.